Page results
-
UCLH patient information for using Control IQ technology
-
UCLH Learning Disabilities and Autism Team Telephone: 020 3447 8238 Email: uclh.referrals.learning.disabilities@nhs.net…
-
This page will give you an overview of intravesical thermo-chemotherapy, how it is given and side effects it may cause.
-
This page will give you an overview of intravesical chemotherapy, how it is given and side effects it may cause.
-
This page will give you an overview of intravesical RF induced thermochemotherapy, how it is given and side effects it may cause.
-
The following information has been written by the Specialist Physiotherapist who works for the Mitochondrial service. The page provides information about activity and exercise for people living with…
-
Benefits of exercise Improve aerobic conditioning (physical activity endurance). Improve efficiency in getting into the second wind. Prevent muscle weakness due to inactivity. Control…
-
This page will give you an overview of intravesical chemotherapy, how it is given and side effects it may cause.
-
This booklet has been written by tracheostomy team at The National Hospital for Neurology and Neurosurgery. It is intended to provide information for patients (or their families and carers) about…
File results
-
FOI/2023/0425 - Trusts temp agency spend for doctors, nurses and allied health professionals (AHP) - 2022/23
-
FOI/2023/0430 - Number of operations performed to remove rectal foreign bodies
-
FOI/2023/0437 - Outsourced and insourced procedures for dermatology, endoscopy and gynaecology procedures from 2017/18-2022/23
-
FOI/2023/0438 - Outsourced and insourced procedures dermatology, endoscopy and gynaecological procedures
-
FOI/2023/0446 - Senior staff contact details
-
FOI/2024/0236 - Proton Beam Therapy Centre
-
FOI/2023/0457 - Psychiatric/ behavioural problems linked to psychiatric disorders use of force policies
-
FOI/2023/0525 - Senior doctors/ consultants/ junior doctors pay
-
FOI/2023/0559 - Patients admitted to hospital with dental distress
-
FOI/2023/0515 - Visitor policy in response to Covid-19